Roche Gives Up on India Patent for Breast Cancer DrugRoche Gives Up on India Patent for Breast Cancer Drug

Roche Holding AG has decided not to pursue a patent application for its breast cancer drug Herceptin (trastuzumab) in India, the Swiss company said. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news